Zuojin Pill ameliorates depression with gastrointestinal dysfunction via Parabacteroides distasonis
Phytomedicine · 2026-07 · 156 · 158173
DOI: 10.1016/j.phymed.2026.158173 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Dan Qiao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nanjing First Hospital, Nanjing University of Chinese Medicine, Nanjing, China; Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Depression, Dyspepsia, Gastrointestinal Diseases. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND Brain-gut interaction disorders, such as functional dyspepsia (FD) comorbid with depression, are highly prevalent and severely affect patients' quality of life; however, the underlying mechanisms remain incompletely understood, and effective therapeutic options are still limited. Zuojin Pill (ZJP), a classic Chinese herbal formula, has shown potential in treating both gastrointestinal disorders and depressive symptoms, but its role in FD-depression comorbidity and underlying mechanisms remain unclear. PURPOSE This investigation aimed to evaluate the therapeutic potential of ZJP and delineate its mechanistic pathways in alleviating comorbid depressive symptoms and Gastrointestinal (GI) impairments. STUDY DESIGN A combined clinical observational study and preclinical experimental study was conducted to integrate human and animal data for mechanistic validation. METHODS Baseline assessments were conducted in healthy controls and patients with functional dyspepsia (FD)-depression comorbidity, including evaluations of gut microbiota composition, metabolite profiles, inflammatory cytokines, gastrointestinal hormones, and serotonin (5-HT) levels. An animal model using mice was developed to assess the efficacy of ZJP in addressing depression-related phenotypes and GI functional deficits. Furthermore, Parabacteroides distasonis was used to induce pathological features in mice, and the intervention effects of ZJP were systematically assessed. RESULTS Patients with FD-depression comorbidity exhibited gut microbiota dysbiosis, characterized by a significant increase in P. distasonis abundance. Metabolomic analysis highlighted tryptophan metabolism as a key altered pathway. In model mice, ZJP administration alleviated depression-like behaviors and gastrointestinal dysfunction. Mechanistically, ZJP targeted P. distasonis, regulated tryptophan-derived metabolites, enhanced anti-inflammatory cytokine expression, improved synaptic plasticity, and restored intestinal mucosal barrier integrity. CONCLUSIONS ZJP ameliorates depression with gastrointestinal dysfunction by modulating P. distasonis and its associated tryptophan metabolic pathway, thereby restoring gut-brain axis homeostasis. These results establish a mechanistic foundation supporting the therapeutic use of ZJP in treating brain-gut interaction disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanjing First Hospital, Nanjing University of Chinese Medicine, Nanjing, China; Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
- Department of Gastroenterology, Lianshui People's Hospital Affiliated to Kangda College of Nanjing Medical University, Huai an, China. Electronic address: 0826hxs@163.com.
- School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Electronic address: taoww@njucm.edu.cn.
- Nanjing First Hospital, Nanjing University of Chinese Medicine, Nanjing, China; Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: njzxjh001@njucm.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qiao, D., Huang, Y., Ge, C., Ma, M., Gu, M., Chen, B., Wu, Y., Zhao, S., Li, J., Kang, N., Cai, Z., Huang, S., Tao, W., & Liu, W. (2026). Zuojin Pill ameliorates depression with gastrointestinal dysfunction via Parabacteroides distasonis. Phytomedicine, 156, 158173. https://doi.org/10.1016/j.phymed.2026.158173
Vancouver
Qiao D, Huang Y, Ge C, Ma M, Gu M, Chen B, et al. Zuojin Pill ameliorates depression with gastrointestinal dysfunction via Parabacteroides distasonis. Phytomedicine. 2026;156:158173. doi:10.1016/j.phymed.2026.158173
BibTeX
@article{Qiao2026,
author = {Qiao, Dan and Huang, Yuzhen and Ge, Chun and Ma, Mengqing and Gu, Mengmeng and Chen, Bo and Wu, Yuqi and Zhao, Shuang and Li, Jiaqi and Kang, Ning and Cai, Zelin and Huang, Shu and Tao, Weiwei and Liu, Wanli},
title = {Zuojin Pill ameliorates depression with gastrointestinal dysfunction via Parabacteroides distasonis},
journal = {Phytomedicine},
year = {2026},
volume = {156},
pages = {158173},
doi = {10.1016/j.phymed.2026.158173}
}
EUVIMED